1. Home
  2. PHAR
  3. PHAR News

Latest Pharming Group N.V. (PHAR) News on November 17, 2024

Pharming Group to participate in November investor conference
PHAR

GlobeNewswire

12 days ago

Pharming Group to participate in November investor conference

High Growth Tech And 2 Other Promising Stocks To Watch
PHAR

Simply Wall St.

13 days ago

High Growth Tech And 2 Other Promising Stocks To Watch

Pharming Group (PHGUF) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
PHAR

GuruFocus.com

23 days ago

Pharming Group (PHGUF) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

Pharming Group reports third quarter 2024 financial results and provides business update
PHAR

GlobeNewswire

24 days ago

Pharming Group reports third quarter 2024 financial results and provides business update

October 2024's Promising Penny Stocks to Watch
PHAR

Simply Wall St.

a month ago

October 2024's Promising Penny Stocks to Watch

Pharming Group to report third quarter 2024 financial results on October 24
PHAR

GlobeNewswire

a month ago

Pharming Group to report third quarter 2024 financial results on October 24

Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last?
PHAR

Zacks

a month ago

Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last?

PHAR

MT Newswires

2 months ago

Pharming Group Gets Marketing Approval in UK for Immunodeficiency Drug

Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)
PHAR

GlobeNewswire

2 months ago

Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)

Pharming Group to participate in September investor conferences
PHAR

GlobeNewswire

2 months ago

Pharming Group to participate in September investor conferences

Pharming Group reports second quarter and first half 2024 financial results and provides business update
PHAR

GlobeNewswire

4 months ago

Pharming Group reports second quarter and first half 2024 financial results and provides business update

Pharming Group to report second quarter and first half 2024 financial results on August 1
PHAR

GlobeNewswire

4 months ago

Pharming Group to report second quarter and first half 2024 financial results on August 1

FDA panel votes to recommend Eli Lilly's Alzheimer's drug
PHAR

Yahoo Finance Video

5 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

PHAR

GlobeNewswire

5 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit
PHAR

Reuters

5 months ago

California seeks company profits in Big Oil climate lawsuit

PHAR

USA TODAY

5 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
PHAR

GlobeNewswire

5 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
PHAR

Business Wire

5 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas
PHAR

Business Wire

5 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research
PHAR

GlobeNewswire

5 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge
PHAR

ACCESSWIRE

5 months ago

Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge

Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies
PHAR

Business Insider

5 months ago

Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting
PHAR

GlobeNewswire

5 months ago

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger
PHAR

Motley Fool

5 months ago

Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger

Unifor members vote to strike at Manitoba Hydro
PHAR

CNW Group

5 months ago

Unifor members vote to strike at Manitoba Hydro

Croatia beat Portugal in Euro 2024 warm-up friendly
PHAR

AFP

5 months ago

Croatia beat Portugal in Euro 2024 warm-up friendly

Mark Cuban explains how he helped turn 300 of his employees into millionaires
PHAR

Business Insider

5 months ago

Mark Cuban explains how he helped turn 300 of his employees into millionaires

Here's what to do if you missed out on the massive 54% stock market rally since October 2022
PHAR

Business Insider

5 months ago

Here's what to do if you missed out on the massive 54% stock market rally since October 2022

Shareholders in Pharming Group (AMS:PHARM) are in the red if they invested a year ago
PHAR

Simply Wall St.

5 months ago

Shareholders in Pharming Group (AMS:PHARM) are in the red if they invested a year ago

Pharming Group to participate in June investor conferences
PHAR

GlobeNewswire

5 months ago

Pharming Group to participate in June investor conferences

Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union
PHAR

GlobeNewswire

6 months ago

Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union

Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
PHAR

GlobeNewswire

6 months ago

Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders

Pharming Group to participate in May investor conference
PHAR

GlobeNewswire

6 months ago

Pharming Group to participate in May investor conference

Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025
PHAR

GlobeNewswire

6 months ago

Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025

Pharming Group reports first quarter 2024 financial results and provides business update
PHAR

GlobeNewswire

6 months ago

Pharming Group reports first quarter 2024 financial results and provides business update

Pharming Group to report first quarter 2024 financial results on May 8
PHAR

GlobeNewswire

7 months ago

Pharming Group to report first quarter 2024 financial results on May 8

Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
PHAR

GlobeNewswire

7 months ago

Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards

Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
PHAR

Zacks

7 months ago

Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?

Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025
PHAR

GlobeNewswire

7 months ago

Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025

Pharming Group announces the placement of €100 million convertible bonds due 2029
PHAR

GlobeNewswire

7 months ago

Pharming Group announces the placement of €100 million convertible bonds due 2029

Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025
PHAR

GlobeNewswire

7 months ago

Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025

Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
PHAR

GlobeNewswire

7 months ago

Pharming announces completion of enrollment in pediatric clinical trial of leniolisib

Pharming Group announces the 2024 Annual General Meeting of Shareholders
PHAR

GlobeNewswire

7 months ago

Pharming Group announces the 2024 Annual General Meeting of Shareholders

Pharming Group announces the filing of its 2023 Annual Report and Form 20-F
PHAR

GlobeNewswire

7 months ago

Pharming Group announces the filing of its 2023 Annual Report and Form 20-F

Pharming Group to participate in April investor conferences
PHAR

GlobeNewswire

7 months ago

Pharming Group to participate in April investor conferences

Pharming Group N.V. (AMS:PHARM) Analysts Are Pretty Bullish On The Stock After Recent Results
PHAR

Simply Wall St.

8 months ago

Pharming Group N.V. (AMS:PHARM) Analysts Are Pretty Bullish On The Stock After Recent Results

Pharming Group Full Year 2023 Earnings: US$0.015 loss per share (vs US$0.021 profit in FY 2022)
PHAR

Simply Wall St.

8 months ago

Pharming Group Full Year 2023 Earnings: US$0.015 loss per share (vs US$0.021 profit in FY 2022)

Pharming Group reports fourth quarter and full year 2023 financial results
PHAR

GlobeNewswire

8 months ago

Pharming Group reports fourth quarter and full year 2023 financial results

Pharming Group to report fourth quarter and full year 2023 financial results on March 14
PHAR

GlobeNewswire

9 months ago

Pharming Group to report fourth quarter and full year 2023 financial results on March 14

Pharming Group to participate in February investor conferences
PHAR

GlobeNewswire

9 months ago

Pharming Group to participate in February investor conferences

Forbes Names SP Plus Corporation to its 2024 List of America’s Most Successful Small-Cap Companies
PHAR

GlobeNewswire

10 months ago

Forbes Names SP Plus Corporation to its 2024 List of America’s Most Successful Small-Cap Companies

Earnings Update: Here's Why Analysts Just Lifted Their S&T Bancorp, Inc. (NASDAQ:STBA) Price Target To US$32.50
PHAR

Simply Wall St.

10 months ago

Earnings Update: Here's Why Analysts Just Lifted Their S&T Bancorp, Inc. (NASDAQ:STBA) Price Target To US$32.50

Gentex Corporation (NASDAQ:GNTX) Q4 2023 Earnings Call Transcript
PHAR

Insider Monkey

10 months ago

Gentex Corporation (NASDAQ:GNTX) Q4 2023 Earnings Call Transcript

Bancorp Full Year 2023 Earnings: EPS Misses Expectations
PHAR

Simply Wall St.

10 months ago

Bancorp Full Year 2023 Earnings: EPS Misses Expectations

Earnings Preview: Heartland Express (HTLD) Q4 Earnings Expected to Decline
PHAR

Zacks

10 months ago

Earnings Preview: Heartland Express (HTLD) Q4 Earnings Expected to Decline

PHAR

Thomson Reuters StreetEvents

10 months ago

Q1 2024 Fair Isaac Corp Earnings Call

Decoding Fair Isaac Corp (FICO): A Strategic SWOT Insight
PHAR

GuruFocus.com

10 months ago

Decoding Fair Isaac Corp (FICO): A Strategic SWOT Insight

Coherent Introduces 532 nm HyperRapid NXT Picosecond Laser for Ultraprecision Manufacturing of Thin-Film Solar Cells
PHAR

GlobeNewswire

10 months ago

Coherent Introduces 532 nm HyperRapid NXT Picosecond Laser for Ultraprecision Manufacturing of Thin-Film Solar Cells

18 High Growth Low PE Stocks
PHAR

Insider Monkey

10 months ago

18 High Growth Low PE Stocks

Here's Why Century (CENX) Is a Great 'Buy the Bottom' Stock Now
PHAR

Zacks

10 months ago

Here's Why Century (CENX) Is a Great 'Buy the Bottom' Stock Now

3 Ultra-High-Yield Dividend Stocks That Are Simply Too Cheap to Ignore
PHAR

Motley Fool

10 months ago

3 Ultra-High-Yield Dividend Stocks That Are Simply Too Cheap to Ignore

Despite currently being unprofitable, Transocean (NYSE:RIG) has delivered a 91% return to shareholders over 3 years
PHAR

Simply Wall St.

10 months ago

Despite currently being unprofitable, Transocean (NYSE:RIG) has delivered a 91% return to shareholders over 3 years

PHAR

Thomson Reuters StreetEvents

10 months ago

Q4 2023 OceanFirst Financial Corp Earnings Call

OceanFirst (OCFC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
PHAR

Zacks

10 months ago

OceanFirst (OCFC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Charles Schwab, Instacart, Chinese tech stocks: Trending tickers
PHAR

Yahoo Finance Video

10 months ago

Charles Schwab, Instacart, Chinese tech stocks: Trending tickers

Stiegler EdTech Announces Grant from Live Oak Bank to Expand its Newly Launched Varsity Esports & STEM League to Eastern NC
PHAR

PR Newswire

10 months ago

Stiegler EdTech Announces Grant from Live Oak Bank to Expand its Newly Launched Varsity Esports & STEM League to Eastern NC

Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
PHAR

GlobeNewswire

10 months ago

Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update

This Oil Stock Is Following Leaders ExxonMobil and Occidental Petroleum by Making a Major Acquisition
PHAR

Motley Fool

10 months ago

This Oil Stock Is Following Leaders ExxonMobil and Occidental Petroleum by Making a Major Acquisition

Executive Chairman Robert Friedland to Deliver a Keynote Presentation at the Future Minerals Forum in Riyadh, Saudi Arabia on January 10, 2024
PHAR

ACCESSWIRE

10 months ago

Executive Chairman Robert Friedland to Deliver a Keynote Presentation at the Future Minerals Forum in Riyadh, Saudi Arabia on January 10, 2024

Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)
PHAR

GlobeNewswire

a year ago

Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)

Cohen & Steers Closed-End Funds Declare Distributions for January, February, and March 2024
PHAR

PR Newswire

a year ago

Cohen & Steers Closed-End Funds Declare Distributions for January, February, and March 2024

Companies Like Zai Lab (NASDAQ:ZLAB) Are In A Position To Invest In Growth
PHAR

Simply Wall St.

a year ago

Companies Like Zai Lab (NASDAQ:ZLAB) Are In A Position To Invest In Growth

Should You Be Concerned About The Gorman-Rupp Company's (NYSE:GRC) ROE?
PHAR

Simply Wall St.

a year ago

Should You Be Concerned About The Gorman-Rupp Company's (NYSE:GRC) ROE?

Credicorp Ltd.: Credicorp’s 2024 Quarterly Earnings Releases
PHAR

GlobeNewswire

a year ago

Credicorp Ltd.: Credicorp’s 2024 Quarterly Earnings Releases

Saia holds on to Yellow’s freight
PHAR

FreightWaves

a year ago

Saia holds on to Yellow’s freight

Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib
PHAR

GlobeNewswire

a year ago

Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib

MorphoSys AG (NASDAQ:MOR) Q3 2023 Earnings Call Transcript
PHAR

Insider Monkey

a year ago

MorphoSys AG (NASDAQ:MOR) Q3 2023 Earnings Call Transcript

Alexander & Baldwin Sells Grace Pacific
PHAR

PR Newswire

a year ago

Alexander & Baldwin Sells Grace Pacific

Pharming Group provides updates on EMA regulatory review of leniolisib MAA and plans to file for UK regulatory approval
PHAR

GlobeNewswire

a year ago

Pharming Group provides updates on EMA regulatory review of leniolisib MAA and plans to file for UK regulatory approval

Evergy Announces Third Quarter 2023 Results
PHAR

Business Wire

a year ago

Evergy Announces Third Quarter 2023 Results

Pharming Group announces presentations at International Primary Immunodeficiencies Congress and the American College of Allergy, Asthma & Immunology Annual Scientific Meeting
PHAR

GlobeNewswire

a year ago

Pharming Group announces presentations at International Primary Immunodeficiencies Congress and the American College of Allergy, Asthma & Immunology Annual Scientific Meeting

Share on Social Networks: